PMC:7534795 / 27-132 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":56,"end":64},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T98443","span":{"begin":23,"end":24},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":3,"end":8},"obj":"Chemical"},{"id":"T4","span":{"begin":35,"end":43},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"}],"text":"ty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?"}

{"project":"LitCovid-PubTator","denotations":[{"id":"4","span":{"begin":56,"end":64},"obj":"Disease"},{"id":"5","span":{"begin":76,"end":104},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"tao:has_database_id","subj":"4","obj":"MESH:C000657245"},{"id":"A5","pred":"tao:has_database_id","subj":"5","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?"}